Sopalol 2.5/Sopalol 5

Sopalol 2.5/Sopalol 5 Adverse Reactions

bisoprolol

Manufacturer:

Intas Pharmaceuticals

Distributor:

Berlin Pharm
Full Prescribing Info
Adverse Reactions
>10%: Sopalol 5: Bradycardia in patients with chronic heart failure.
1% to 10%: Sopalol 2.5/Sopalol 5: Cardiovascular: Chest pain (1% to 2%), worsening of pre-existing heart failure in patients with chronic heart failure (Sopalol 5 only).
Central nervous system: Fatigue (dose related 6% to 8%), insomnia (2% to 3%), hypoesthesia (1% to 2%).
Gastrointestinal: Diarrhea (dose related 3% to 4%), nausea (2%), vomiting (1% to 2%).
Neuromuscular & skeletal: Arthralgia (2% to 3%), weakness (dose related ≤ 2%).
Respiratory: Upper respiratory infection (5%), rhinitis (3% to 4%), sinusitis (dose related 2%), dyspnea (1% to 2%).
<1% (limited to important or life-threatening): Sopalol 2.5: Abdominal pain, acne, alopecia, angioedema, anxiety, arrhythmia, asthma, back/neck pain, bradycardia (dose related), bronchitis, bronchospasm, BUN /creatinine increased, claudication, cold extremities, confusion (especially in the elderly), congestive heart failure, constipation, coughing, cutaneous vasculitis, cystitis, depression, dermatitis, dizziness, dyspepsia, dyspnea on exertion, eczema, edema, exfoliative dermatitis, flushing, gastritis, gout, hallucinations, headache, hearing decreased, hyperesthesia, hyperglycemia, hyperkalemia, hyperphosphatemia, hypertriglyceridemia, hypotension, impotence, lacrimation (abnormal), leukopenia, libido decreased, malaise, memory loss, muscle cramps, muscle/joint pain, nervousness, ocular pain/pressure, orthostatic hypotension, palpitations, paresthesia, peptic ulcer, Peyronie's disease, pharyngitis, polyuria, positive ANA titers, pruritus, psoriasis, psoriasiform eruption, purpura, rash, renal colic, restlessness, rhythm disturbances, sleep disturbances, somnolence, syncope, taste abnormality, thrombocytopenia, tinnitus, transaminases increased, tremor, twitching, uric acid increased, vasculitis, vertigo, visual disturbances, weight gain, xerostomia.
Sopalol 5: AV-conduction disturbances, bradycardia in patients with hypertension or angina pectoris, worsening of pre-existing heart failure in patients with hypertension or angina pectoris, reduced tear in patient with contact lenses, and conjunctivitis.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in